Sana Biotechnology SANA Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's stock issuance proceeds?
- Sana Biotechnology (SANA) reported stock issuance proceeds of $59K in Q1 2026.
- How has Sana Biotechnology's stock issuance proceeds changed year-over-year?
- Sana Biotechnology's stock issuance proceeds decreased by 94.8% year-over-year, from $1.13M to $59K.
- What is the long-term trend for Sana Biotechnology's stock issuance proceeds?
- Over 3 years (2021 to 2025), Sana Biotechnology's stock issuance proceeds has grown at a 187.7% compound annual growth rate (CAGR), from $5.35M to $127.28M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.